I would expect the MUR/NMS to become a lot more robust with correct inhaler technique training and referral to GP for high-risk patients. Community pharmacy has at their disposal a patient’s recent history and are in a position to assess compliance as a slip net if not identified by a GP Practice.
Community pharmacy needs to act as a wellness service -educating the patient on how to remain well both in-store and within their local communities.
I wouldn’t expect anything other than the high standard of care which patients have come to expect and receive from a Community pharmacy. In the difficult climate of Community pharmacy now, especially in NI, with no pharmacy contract, we need to get better at MURs and identifying high-risk patients to ensure that we don’t lose some of the great services that we have currently and hopefully promote the profession to deliver more enhanced services going forward. Respiratory care is a great foundation for achieving this.
Community pharmacy needs to consider the inhaler devices they issue against generic prescriptions and engage with the patient to ensure the correct device is dispensed and work with their GP counterparts to prevent any discrepancies.
I have always worked with the ethic -“ensure the right person, gets the right drug, the right way, for the right reason, at the right time” along with “Do No Harm” and if this applied then Respiratory Care from Community pharmacy will be of a very high standard.
Community pharmacy must not shy away from making recommendations as drug specialists to patients and GP practices. In my experience, more often than not, they appreciate the input. It is important though to build great professional relationships with many of the key stakeholders if this is to gather any momentum.